港股低開後倒升逾130點 石藥(01093.HK)中生(01177.HK)各漲逾7% 「明星股」續炒蜜雪(02097.HK)泡泡瑪特(09992.HK)毛戈平(01318.HK)齊破頂
隔晚(3日)美國三大指數收升0.5%至0.8%,市場觀望本周中美貿易對話進展。亞太區主要股市今早(4日)普遍上升,南韓總統大選塵埃落定,韓股復市升2.4%跑贏區內。內地滬深兩市早段升0.33%及0.84%、台股更升1.8%。日經指數升近1%。港股承上日升勢,今早(4日)輕微低開12點後,初段倒升,最新報23,645,續升132點或近0.6%,成交710.25億元。
醫藥股領升,石藥(01093.HK)及中生製藥(01177.HK)升7.8%及7.1%,屬藍籌股升幅首兩位。藥明生物(02269.HK)及翰森(03692.HK)各升逾2%。藥明康德(02359.HK)升1.2%。行業巨擘半新股、有「藥茅」之稱的恆瑞醫藥(01276.HK)亦升2.9%。
另吉利(00175.HK)及美團-W(03690.HK)各升逾3%。攜程-S(09961.HK)逆市跌逾3%,屬藍籌股暫時表現最差。
「明星股」續有炒作。蜜雪(02097.HK)最高見615元屢創新高,最新報607元,升3.58%,成交8,311.5萬元。泡泡瑪特(09992.HK)最高見245元亦創新高。現報240元,升2.56%,成交10.33億元。國產化妝品牌毛戈平(01318.HK)最高見123元創歷史高,現報122.1元,升6.54%,成交2.05億元。
老鋪黃金(06181.HK)高見978元逼近歷史高位(978.5元)。現報973元,升0.88%,成交2.78億元。該股今年以來已累升約3倍。開源證券表示,老鋪黃金本周發布新品「七子葫蘆」等系列,其融合童年IP葫蘆娃引發客群共鳴。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.